跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Sanofi Winthrop Industrie
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
e202ecfca4a27afa
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
e202ecfca4a27afa
Drug Cima Aemps Name
SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201435001IP
Holder Company Name
Sanofi Winthrop Industrie
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/sanofi-winthrop-industrie
Authorization Date
2024-02-13
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Sanofi Winthrop Industrie
Company Detail Path
/organization/sanofi-winthrop-industrie
Company Information
Pharmaceutical Company Name
SANOFI WINTHROP INDUSTRIE
Country Name
France
City Name
amilly,centre val de loire,country_fr
Address
130 RUE DE LA FONTAINE
Active Ingredients
ISATUXIMAB
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
e202ecfca4a27afa
Type
Standard
Back to CIMA-AEMPS Approvals